# Turning Point Brands, Inc.: Form 10-Q for the period ended Jun 30, 2020

- Company: [Turning Point Brands, Inc.](/companies/tpb.md) (CIK 1290677)
- Form: 10-Q
- Filed: 2020-07-28
- Accepted by EDGAR: Jul 28, 2020, 16:26 ET
- Period: 2020-06-30
- Accession: 0001140361-20-016862
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1290677/000114036120016862/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1290677/000114036120016862/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-04-01 to 2020-06-30 | $105.0m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months, 2020-01-01 to 2020-06-30 | $195.7m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months, 2020-04-01 to 2020-06-30 | $56.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2020-01-01 to 2020-06-30 | $106.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-04-01 to 2020-06-30 | $48.1m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2020-01-01 to 2020-06-30 | $89.5m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2020-04-01 to 2020-06-30 | $30.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2020-01-01 to 2020-06-30 | $63.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-04-01 to 2020-06-30 | $17.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2020-01-01 to 2020-06-30 | $26.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2020-04-01 to 2020-06-30 | $3.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2020-01-01 to 2020-06-30 | $4.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-04-01 to 2020-06-30 | $9.2m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2020-01-01 to 2020-06-30 | $12.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-04-01 to 2020-06-30 | $0.47 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2020-01-01 to 2020-06-30 | $0.63 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-04-01 to 2020-06-30 | $0.47 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2020-01-01 to 2020-06-30 | $0.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-04-01 to 2020-06-30 | 19,834,345 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2020-01-01 to 2020-06-30 | 19,872,726 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2020-01-01 to 2020-06-30 | $17.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-04-01 to 2020-06-30 | $1.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months, 2020-01-01 to 2020-06-30 | $2.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2020-01-01 to 2020-06-30 | $1.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2020-01-01 to 2020-06-30 | $5.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-06-30 | $64.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-06-30 | $161.6m | us-gaap:AssetsCurrent |
| Total assets | at 2020-06-30 | $467.2m | us-gaap:Assets |
| Current liabilities | at 2020-06-30 | $52.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-06-30 | $355.5m | us-gaap:Liabilities |
| Long-term debt | at 2020-06-30 | $284.6m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2020-06-30 | $111.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 49,575 characters.

*You should read the following discussion of the historical financial condition and results of operations in conjunction with our historical consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q. In addition, this discussion includes forward-looking statements subject to risks and uncertainties that may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors.”*

*The following discussion relates to the unaudited financial statements of Turning Point Brands, Inc., included elsewhere in this Quarterly Report on Form 10-Q. In this discussion, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and its consolidated subsidiaries. References to “TPB” refer to Turning Point Brands, Inc., without any of its subsidiaries. We were incorporated in 2004 under the name North Atlantic Holding Company, Inc. On November 4, 2015, we changed our name to Turning Point Brands, Inc. Many of the amounts and percentages in this discussion have been rounded for convenience of presentation.*

### Organizational Structure

We, Turning Point Brands, Inc., are a holding company which owns North Atlantic Trading Company, Inc. (“NATC”), and its subsidiaries, Turning Point Brands, LLC (“TPLLC”), and its subsidiaries, Standard Merger Sub, LLC (“SMS”), North Atlantic Wrap Company, LLC (“NAWC”), TPB Services, LLC (“TPBS”), and Turning Point Brands (Canada) Inc. (“TPBC”). NATC includes subsidiaries National Tobacco Company, L.P. (“NTC”), National Tobacco Finance, LLC (“NTFLLC”), North Atlantic Operating Company, Inc. (“NAOC”), North Atlantic Cigarette Company, Inc. (“NACC”), and RBJ Sales, Inc. (“RBJ”). TPLLC includes subsidiaries Intrepid Brands, LLC (“Intrepid”), TPB Beast, LLC (“VaporBeast”), TPB Shark, LLC, and its subsidiaries (collectively, “Vapor Shark”), TPB International, LLC and its subsidiaries (collectively, “IVG”), Nu-X Ventures LLC (“Nu-X”), Nu-Tech Holdings LLC (“Nu-Tech”), and South Beach Holdings, LLC (“South Beach”).

### Overview

Turning Point Brands, Inc. (the “Company,” “we,” “our,” or “us”) is a leading, independent provider of Other Tobacco Products (“OTP”) and adult consumer alternatives. We estimate the OTP industry generated approximately $11.5 billion of manufacturer revenue in 2019. In contrast to manufactured cigarettes, which have been experiencing declining volumes for decades based on data published by the Alcohol and Tobacco Tax and Trade Bureau (“TTB”), the OTP industry is demonstrating increased consumer appeal with low to mid-single digit consumer unit growth as reported by Management Science Associates, Inc. (“MSAi”), a third-party analytics and information company. We were the 6th largest competitor in terms of total OTP consumer units sold during 2019. We sell a wide range of products across the OTP spectrum; however, we do not sell cigarettes. Our portfolio of brands includes some of the most widely recognized names in the OTP industry, such as *Zig-Zag®, Beech-Nut®, Stoker’s®, Trophy®, VaporBeast®* and *VaporFi®*. We currently ship to approximately 900 distributors with an additional 100 secondary, indirect wholesalers in the U.S. that carry and sell our products. We operate in three segments: (i) Smokeless products, (ii) Smoking products, and (iii) NewGen products. Under the leadership of a senior management team with an average of 24 years of experience in the tobacco industry, we have grown and diversified our business through new product launches, category expansions, and acquisitions while concurrently improving operational efficiency.

We have identified additional growth opportunities in the emerging alternatives market. In January 2019, we established our subsidiary, Nu-X, a new company and wholly-owned subsidiary dedicated to the development, production and sale of alternative products and acquisitions in related spaces. The creation of Nu-X allows TPB to leverage its expertise in traditional OTP management to alternative products. The TPB management team has over 100 years of experience navigating federal, state and local regulations that are directly applicable to the growing alternatives market. In July 2019, we acquired the assets of Solace Technology (“Solace”). Solace is an innovative product development company which established one of the top e-liquid brands and has since grown into a leader in alternative products. Solace’s legacy and innovation will enhance Nu-X’s strong and nimble development engine. In July 2019, we acquired a 30% stake in ReCreation Marketing (“ReCreation). ReCreation is a specialty marketing and distribution firm focused on building brands in the Canadian smoking, vaping and alternative products categories. The investment will leverage ReCreation’s significant expertise in marketing and distributing tobacco and cannabis products throughout Canada. The investment is part of Nu-X and we plan to make additional investments, partnerships and acquisitions to drive the business of Nu-X. These endeavors will enable us to continue to identify unmet customer needs and provide quality products that we believe will result in genuine customer satisfaction and foster the growth of revenue.

We believe there are meaningful opportunities to grow our business organically and through acquisitions and joint ventures across all product categories. As of December 31, 2019, our products are available in approximately 185,000 U.S. retail locations which, with the addition of retail stores in Canada, brings our total North American retail presence to an estimated 210,000 points of distribution. Our sales team targets widespread distribution to all traditional retail channels, including convenience stores.

#### Products

We operate in three segments: Smokeless products, Smoking products and NewGen products. In our Smokeless products segment, we (i) manufacture and market moist snuff and (ii) contract for and market loose leaf chewing tobacco products. In our Smoking products segment, we principally (i) market and distribute cigarette papers, tubes, and related products; and (ii) contract for, market and distribute finished cigars and MYO cigar wraps. In our NewGen products segment, we (i) market and distribute CBD, liquid vapor products and certain other products without tobacco and/or nicotine; (ii) distribute a wide assortment of products to non-traditional retail via VaporBeast; and (iii) market and distribute a wide assortment of products to individual consumers via the VaporFi B2C online platform. Our portfolio of brands includes some of the most widely recognized names in the OTP industry such as *Stoker’s®* in the Smokeless segment, *Zig-Zag®* in the Smoking segment, and *VaporBeast®, VaporFi®* and *Solace©* in the NewGen segment.

#### Operations

Our core tobacco business (Smokeless and Smoking segments) primarily generates revenues from the sale of our products to wholesale distributors who, in turn, resell the products to retail operations. Our acquisition of VaporBeast in 2016 expanded our revenue streams as we began selling directly to non-traditional retail outlets. Our acquisition of IVG in 2018 enhanced our business-to-consumer revenue stream with the addition of the Vapor-Fi online platform. Our net sales, which include federal excise taxes, consist of gross sales net of cash discounts, returns, and selling and marketing allowances.

We rely on long-standing relationships with high-quality, established manufacturers to provide the majority of our produced products. More than 80% of our production, as measured by net sales, is outsourced to suppliers. The remaining production consists of our moist snuff tobacco operations located in Dresden, Tennessee, and Louisville, Kentucky and the proprietary e-liquids operations located in Louisville, Kentucky. Our principal operating expenses include the cost of raw materials used to manufacture the limited number of our products which we produce in-house; the cost of finished products, which are generally purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel. Our other principal expenses include interest expense and other expenses.

### Key Factors Affecting Our Results of Operations

We consider the following to be the key factors affecting our results of operations:

- Our ability to further penetrate markets with our existing products;
- Our ability to introduce new products and product lines that complement our core business;
- Decreasing interest in some tobacco products among consumers;
- Price sensitivity in our end-markets;
- Marketing and promotional initiatives, which cause variability in our results;
- General economic conditions, including consumer access to disposable income;
- Cost and increasing regulation of promotional and advertising activities;
- Cost of complying with regulation, including the “deeming regulations”;
- Counterfeit and other illegal products in our end-markets;
- Currency fluctuations;
- Our ability to identify attractive acquisition opportunities in OTP; and
- Our ability to integrate acquisitions.

### Recent Developments

#### Durfort Holdings

In June 2020, we purchased certain tobacco assets and distribution rights from Durfort Holdings S.R.L. (“Durfort”) and Blunt Wrap USA for $47.8 million in total consideration, comprised of $37.8 million in cash, including $1.8 million of capitalized transaction costs, and a $10.0 million Promissory Note. With this transaction, we acquired co-ownership in the intellectual property rights of all of Durfort’s and Blunt Wrap USA’s HTL cigar wraps and cones. We also entered into an exclusive Master Distribution Agreement to market and sell the original *Blunt Wrap®* cigar wraps within the USA which is expected to be effective within 120 days of the closing. Durfort is an industry leader in alternative cigar and cigar wrap manufacturing and distribution. Blunt Wrap USA has been an innovator of new products in the smoking alternative market since 1997 and has secured patents in the USA and internationally for novel smoking wrappers and cones.

#### COVID-19 Impact

As a result of the extraordinary situation we are facing, our focus is on the safety and well-being of our colleagues and the communities and customers we serve. As an organization, we have implemented several changes to enhance safety and mitigate health risk in our work environment. For our warehouse and manufacturing operations, these include split shifts, temperature scans, additional contactless hand sanitizing stations, protective equipment, social distancing guidelines, and increased cleaning and sanitization. These changes resulted in higher operational costs related to maintaining a safer work environment and fulfilling orders.

We canceled all unnecessary travel and facilitated telecommuting where possible. Like many companies, we have changed the way we communicate through increased use of videoconferencing and have implemented tele-selling initiatives through our sales force. Some of these changes that are proving to be efficient are likely to remain in-place even after this crisis and lead to on-going cost savings. We have also put a hold on new spending commitments as we cautiously manage through this environment.

We hired additional employees in our Louisville facility and implemented temporary wage increases for our hourly employees to meet increased demand. We shifted production capacity to manufacture hand sanitizers and have donated bottles to hospitals, nursing homes and first responders in our local communities.

COVID-19 may impact our results. Our third-party cigar wrap manufacturer in the Dominican Republic was temporarily shut down. Our supply chain has remained operational otherwise. In-person selling has been dramatically dampened, which may affect new product launches. Select budgeted annual price increases will be delayed. Our B2C platforms have seen elevated sales levels from consumer shifts to online purchasing and we gained market share. We continue to monitor this challenging environment closely and will make necessary adjustments as needed to make sure we are serving our employees and customers, while also protecting the safety of employees and communities.

#### Standard Diversified Inc. (“SDI”) Reorganization

On July 16, 2020, we completed our merger with SDI, whereby SDI was merged into a wholly-owned subsidiary of TPB in a tax-free downstream merger. Under the terms of the agreement, the holders of SDI’s Class A Common Stock and SDI’s Class B Common Stock (collectively, “SDI Common Stock”) received in the aggregate, in return for their SDI Common Stock, TPB Voting Common Stock (“TPB Common Stock”) at a ratio of 0.52095 shares of TPB Common Stock for each share SDI Common Stock. SDI divested its assets prior to close such that the net liabilities at closing did not exceed $25,000 (whole dollars) and the only assets that it retained was the remaining TPB Common Stock holdings. We no longer have a controlling shareholder and 245,234 shares of TPB Common Stock were retired. The transaction significantly improved the public float of shares outstanding and eliminated the overhang of a controlling holding company structure.

#### Premarket Tobacco Application Deadline Extension

The United States District Court for the District of Maryland agreed to an FDA request filed for a 120-day extension of the premarket tobacco application deadline for many e-cigarettes, cigars and other tobacco products. FDA stated that the extension was needed because of the impacts of the coronavirus on both the agency and the industry. The Court-modified Remedy Order had the effect of moving the premarket filing deadline from May 12, 2020 to September 9, 2020. FDA subsequently issued Guidance in line with the modified Remedy Order.

### Critical Accounting Policies and Uses of Estimates

There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2019 Annual Report on Form 10-K.

### Recent Accounting Pronouncements

Refer to Note 2, “Summary of Significant Accounting Policies”, of Notes to Consolidated Financial Statements included in this Quarterly Report for a description of recently issued accounting pronouncements, including those recently adopted.

### Results of Operations

#### Comparison of the Three Months Ended June 30, 2020, to the Three Months Ended June 30, 2019

The table and discussion set forth below displays our consolidated results of operations (in thousands):

| Consolidated Results of Operations Data: Net sales | Three Months Ended June 30, 2020 | 2019 | % Change |
| --- | ---: | ---: | ---: |
| Smokeless products | $30,822 | $26,176 | 17.7% |
| Smoking products | 27,403 | 25,363 | 8.0% |
| NewGen products | 46,738 | 41,800 | 11.8% |
| Total net sales | 104,963 | 93,339 | 12.5% |
| Cost of sales | 56,871 | 52,156 | 9.0% |
| Gross profit |  |  |  |
| Smokeless products | 16,664 | 14,063 | 18.5% |
| Smoking products | 15,671 | 13,738 | 14.1% |
| NewGen products | 15,757 | 13,382 | 17.7% |
| Total gross profit | 48,092 | 41,183 | 16.8% |
| Selling, general, and administrative expenses | 30,756 | 21,242 | 44.8% |
| Operating income | 17,336 | 19,941 | -13.1% |
| Interest expense, net | 4,980 | 3,736 | 33.3% |
| Investment income | (34) | (118) | -71.2% |
| Loss on extinguishment of debt | - | 150 |  |
| Net periodic income, excluding service cost | (104) | (11) | 845.5% |
| Income before income taxes | 12,494 | 16,184 | -22.8% |
| Income tax expense | 3,267 | 2,979 | 9.7% |
| Consolidated net income | $9,227 | $13,205 | -30.1% |

36

**Net Sales:** For the three months ended June 30, 2020, consolidated net sales increased to $105.0 million from $93.3 million for the three months ended June 30, 2019, an increase of $11.6 million or 12.5%. The increase in net sales was driven by increased volume across all segments in 2020.

For the three months ended June 30, 2020, net sales in the Smokeless products segment increased to $30.8 million from $26.2 million for the three months ended June 30, 2019, an increase of $4.6 million or 17.7%. For the three months ended June 30, 2020, volume increased 13.9% and price/mix increased 3.8%. The increase in net sales was driven by the continuing double-digit volume growth of *Stoker’s®* MST. Sales in chewing tobacco products were up mid-single digits as compared to prior year.

For the three months ended June 30, 2020, net sales in the Smoking products segment increased to $27.4 million from $25.4 million for the three months ended June 30, 2019, an increase of $2.0 million or 8.0%. For the three months ended June 30, 2020, volume increased 7.5% and price/mix increased 0.5%. The increase in net sales is primarily related to double digit growth in US rolling papers and Canada papers, partially offset by a $2.4 million decline in MYO cigar wraps due to COVID-19 related supply disruption and a $0.4 million decline in non-focus cigars and MYO.

For the three months ended June 30, 2020, net sales in the NewGen products segment increased to $46.7 million from $41.8 million for the three months ended June 30, 2019, an increase of $4.9 million or 11.8%. The increase in net sales is the result of strong market share gains in our vape distribution business and positive contributions from Solace and other Nu-X products.

**Gross Profit:** For the three months ended June 30, 2020, consolidated gross profit increased to $48.1 million from $41.2 million for the three months ended June 30, 2019, an increase of $6.9 million or 16.8%. Gross profit as a percentage of revenue increased to 45.8% for the three months ended June 30, 2020, compared to 44.1% for the three months ended June 30, 2019.

For the three months ended June 30, 2020, gross profit in the Smokeless products segment increased to $16.7 million from $14.1 million for the three months ended June 30, 2019, an increase of $2.6 million or 18.5%. Gross profit as a percentage of net sales increased to 54.1% of net sales for the three months ended June 30, 2020, from 53.7% of net sales for the three months ended June 30, 2019, primarily as a as a result of strong incremental margin contribution of MST.

For the three months ended June 30, 2020, gross profit in the Smoking products segment increased to $15.7 million from $13.7 million for the three months ended June 30, 2019, an increase of $1.9 million or 14.1%. Gross profit as a percentage of net sales increased to 57.2% of net sales for the three months ended June 30, 2020, from 54.2% of net sales for the three months ended June 30, 2019, as a result of increased US rolling paper sales and a continued decline in the low margin cigar business. For the three months ended June 30, 2020 non-focus cigar and MYO pipe sales declined $0.4 million as compared to the three months ended June 30, 2019.

For the three months ended June 30, 2020, gross profit in the NewGen products segment increased to $15.8 million from $13.4 million for the three months ended June 30, 2019, an increase of $2.4 million or 17.7%. Gross profit as a percentage of net sales increased to 33.7% of net sales for the three months ended June 30, 2020, from 32.0% of net sales for the three months ended June 30, 2019 primarily due to an increase in mix of proprietary products and strong growth from our higher gross margin B2C business. For the three months ended June 30, 2020, gross profit included $3.6 million of tariff expenses compared to $2.0 million for the three months ended June 30, 2019.

**Selling, General, and Administrative Expenses:** For the three months ended June 30, 2020, selling, general, and administrative expenses increased to $30.8 million from $21.2 million for the three months ended June 30, 2019, an increase of $9.5 million or 44.8%. Selling, general and administrative expenses in the three months ended June 30, 2020 included $0.8 million of stock options, restricted stock and incentives expense, $0.3 million of transaction expenses and $3.3 million of expense related to PMTA. Selling, general and administrative expenses in the three months ended June 30, 2019 included $1.2 million of stock option, restricted stock and incentives expense, $0.2 million of transaction costs, $0.2 million in corporate and vapor restructuring and $1.3 million of new product launch costs for Nu-X products. These costs were partially offset by a net $5.5 million gain related to the settlement of the VMR Distribution and Supply agreement during the second quarter 2019.

**Interest Expense, net:** For the three months ended June 30, 2020, as a result of the amortization of the debt discount on the Convertible Senior Notes of $1.8 million, interest expense, net increased to $5.0 million, from $3.7 million for the three months ended June 30, 2019.

**Investment Income:** Investment income relating to investment of the MSA deposits was less than $0.1 million for the three months ended June 30, 2020, compared to approximately $0.1 million for the three months ended June 30, 2019.

**Loss on Extinguishment of Debt:** There was no loss on extinguishment of debt for the three months ended June 30, 2020, compared to $0.2 million for the three months ended June 30, 2019 related to the payment on the 2018 Second Lien Credit Facility.

**Net Periodic Income:** Net periodic income was $0.1 million for the three months ended June 30, 2020 and less than $0.1 million for the three months ended June 30, 2019.

**Income Tax Expense:** Our income tax expense of $3.3 million was 26.1% of income before income taxes for the three months ended June 30, 2020. Our effective income tax rate of 18.4% for the three months ended June 30, 2019 included a discrete tax deduction $0.9 million relating to stock option exercises.

**Consolidated Net Income:** Due to the factors described above, consolidated net income for the three months ended June 30, 2020 and 2019, was $9.2 million and $13.2 million, respectively.

#### Comparison of the Six Months Ended June 30, 2020, to the Six Months Ended June 30, 2019

The table and discussion set forth below displays our consolidated results of operations (in thousands):

| Consolidated Results of Operations Data: Net sales | Six Months Ended June 30, 2020 | 2019 | % Change |
| --- | ---: | ---: | ---: |
| Smokeless products | $57,317 | $48,720 | 17.6% |
| Smoking products | 56,317 | 50,882 | 10.7% |
| NewGen products | 82,018 | 85,365 | -3.9% |
| Total net sales | 195,652 | 184,967 | 5.8% |
| Cost of sales | 106,129 | 103,320 | 2.7% |
| Gross profit |  |  |  |
| Smokeless products | 30,538 | 26,136 | 16.8% |
| Smoking products | 31,803 | 27,222 | 16.8% |
| NewGen products | 27,182 | 28,289 | -3.9% |
| Total gross profit | 89,523 | 81,647 | 9.6% |
| Selling, general, and administrative expenses | 63,150 | 49,671 | 27.1% |
| Operating income | 26,373 | 31,976 | -17.5% |
| Interest expense, net | 9,974 | 7,592 | 31.4% |
| Investment income | (125) | (262) | -52.3% |
| Loss on extinguishment of debt | - | 150 |  |
| Net periodic income, excluding service cost | (191) | (22) | 768.2% |
| Income before income taxes | 16,715 | 24,518 | -31.8% |
| Income tax expense | 4,213 | 4,753 | -11.4% |
| Consolidated net income | $12,502 | $19,765 | -36.7% |

**Net Sales:** For the six months ended June 30, 2020, consolidated net sales increased to $195.7 million from $185.0 million for the six months ended June 30, 2019, an increase of $10.7 million or 5.8%. The increase in net sales was primarily driven by increased sales volume in the Smoking and Smokeless segments, partially offset by lower sales in the NewGen segment.

For the six months ended June 30, 2020, net sales in the Smokeless products segment increased to $57.3 million from $48.7 million for the six months ended June 30, 2019, an increase of $8.6 million or 17.6%. For the six months ended June 30, 2020, volume increased 15.2% and price/mix increased 2.4%. The increase in net sales was primarily driven by the continuing double-digit volume growth of *Stoker’s®* MST.

For the six months ended June 30, 2020, net sales in the Smoking products segment increased to $56.3 million from $50.9 million for the six months ended June 30, 2019, an increase of $5.4 million or 10.7%. For the six months ended June 30, 2020, volume increased 9.2% and price/mix increased 1.5%. The increase in net sales is primarily related to double digit growth in US and Canada papers, partially offset by a $0.9 million decline in non-focus cigars and MYO pipe.

For the six months ended June 30, 2020, net sales in the NewGen products segment decreased to $82.0 million from $85.4 million for the six months ended June 30, 2019, a decrease of $3.3 million or 3.9%. The decrease in net sales is primarily the result of the discontinuance of V2 at the end of the second quarter 2019.

**Gross Profit:** For the six months ended June 30, 2020, consolidated gross profit increased to $89.5 million from $81.6 million for the six months ended June 30, 2019, an increase of $7.9 million or 9.6%. Gross profit as a percentage of revenue increased to 45.8% for the six months ended June 30, 2020, compared to 44.1% for the six months ended June 30, 2019.

For the six months ended June 30, 2020, gross profit in the Smokeless products segment increased to $30.5 million from $26.1 million for the six months ended June 30, 2019, an increase of $4.4 million or 16.8%. Gross profit as a percentage of net sales decreased to 53.3% of net sales for the six months ended June 30, 2020, from 53.6% of net sales for the six months ended June 30, 2019, primarily as a result of strong incremental margin contribution of MST.

For the six months ended June 30, 2020, gross profit in the Smoking products segment increased to $31.8 million from $27.2 million for the six months ended June 30, 2019, an increase of $4.6 million or 16.8%. Gross profit as a percentage of net sales increased to 56.5% of net sales for the six months ended June 30, 2020, from 53.5% of net sales for the six months ended June 30, 2019, as a result of increased US and Canada paper sales and a continued decline in the low margin cigar business. For the six months ended June 30, 2020 non-focus cigar and MYO pipe sales declined $0.9 million as compared to the six months ended June 30, 2019.

For the six months ended June 30, 2020, gross profit in the NewGen products segment decreased to $27.2 million from $28.3 million for the six months ended June 30, 2019, a decrease of $1.1 million or 3.9%. Gross profit as a percentage of net sales remained flat at 33.1% of net sales for the six months ended June 30, 2020 and June 30, 2019. For the six months ended June 30, 2020, gross profit included $6.4 million of tariff expenses compared to $4.0 million for the six months ended June 30, 2019.

**Selling, General, and Administrative Expenses:** For the six months ended June 30, 2020, selling, general, and administrative expenses increased to $63.2 million from $49.7 million for the six months ended June 30, 2019, an increase of $13.5 million or 27.1%. Selling, general and administrative expenses in the six months ended June 30, 2020 included $1.2 million of stock options, restricted stock and incentives expense, $1.3 million of transaction expenses and $9.2 million of expense related to PMTA. Selling, general and administrative expenses in the six months ended June 30, 2019 included $1.9 million of stock option, restricted stock and incentives expense, $1.1 million of transaction costs, $1.2 million in corporate and vapor restructuring and $1.7 million of new product launch costs for Nu-X products. These costs were partially offset by a net $5.5 million gain related to the settlement of the VMR Distribution and Supply agreement during the second quarter 2019.

**Interest Expense, net:** For the six months ended June 30, 2020, as a result of the amortization of the debt discount on the Convertible Senior Notes of $3.5 million, interest expense, net increased to $10.0 million, from $7.6 million for the six months ended June 30, 2019.

**Investment Income:** Investment income relating to investment of the MSA deposits was $0.1 million for the six months ended June 30, 2020, compared to $0.3 million for the six months ended June 30, 2019.

**Loss on Extinguishment of Debt:** There was no loss on extinguishment of debt for the six months ended June 30, 2020, compared to $0.2 million for the six months ended June 30, 2019 related to the payment on the 2018 Second Lien Credit Facility.

**Net Periodic Income:** Net periodic income was $0.2 million for the six months ended June 30, 2020 and less than $0.1 million for the six months ended June 30, 2019.

**Income Tax Expense:** Our income tax expense of $4.2 million was 25.2% of income before income taxes for the six months ended June 30, 2020 and included a discrete tax deduction of $3.7 million relating to stock option exercises. Our effective income tax rate of 19.4% for the six months ended June 30, 2019 included a discrete tax deduction of $4.5 million relating to stock option exercises.

**Consolidated Net Income:** Due to the factors described above, consolidated net income for the six months ended June 30, 2020 and 2019, was $12.5 million and $19.8 million, respectively.

### EBITDA and Adjusted EBITDA

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to operating performance. In addition, our credit agreements contain financial covenants which use Adjusted EBITDA calculations.

We define “EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, and amortization. We define “Adjusted EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider ordinary course in our evaluation of ongoing operating performance.

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide reconciliations between net income and Adjusted EBITDA.

*(in thousands)*

|  | Three Months Ended June 30, 2020 | 2019 |
| --- | ---: | ---: |
| Consolidated net income | $9,227 | $13,205 |
| Add: |  |  |
| Interest expense, net | 4,980 | 3,736 |
| Loss on extinguishment of debt | - | 150 |
| Income tax expense | 3,267 | 2,979 |
| Depreciation expense | 822 | 632 |
| Amortization expense | 402 | 364 |
| EBITDA | $18,698 | $21,066 |
| Components of Adjusted EBITDA |  |  |
| Other (a) | (260) | (97) |
| Stock options, restricted stock, and incentives expense (b) | 760 | 1,198 |
| Transaction expenses (c) | 290 | 187 |
| New product launch costs (d) | - | 1,270 |
| Corporate and vapor restructuring (e) | - | 150 |
| FDA PMTA (f) | 3,290 | - |
| Vendor settlement (g) | - | (5,522) |
| Adjusted EBITDA | $22,778 | $18,252 |

(a) Represents LIFO adjustment, non-cash pension expense (income) and foreign exchange hedging.

(b) Represents non-cash stock options, restricted stock, incentives expense and Solace PRSUs.

(c) Represents the fees incurred for transaction expenses.

(d) Represents product launch costs for our new product lines.

(e) Represents costs associated with corporate and vapor restructuring including severance and inventory reserves.

(f) Represents costs associated with applications related to FDA PMTA.

(g) Represents net gain associated with the settlement of a vendor contract.

41

*(in thousands)*

|  | Six Months Ended June 30, 2020 | 2019 |
| --- | ---: | ---: |
| Consolidated net income | $12,502 | $19,765 |
| Add: |  |  |
| Interest expense, net | 9,974 | 7,592 |
| Loss on extinguishment of debt | - | 150 |
| Income tax expense | 4,213 | 4,753 |
| Depreciation expense | 1,673 | 1,163 |
| Amortization expense | 827 | 723 |
| EBITDA | $29,189 | $34,146 |
| Components of Adjusted EBITDA |  |  |
| Other (a) | (347) | (176) |
| Stock options, restricted stock, and incentives expense (b) | 1,215 | 1,913 |
| Transaction expenses (c) | 1,339 | 1,097 |
| New product launch costs (d) | - | 1,712 |
| Corporate and vapor restructuring (e) | - | 1,154 |
| FDA PMTA (f) | 9,164 | - |
| Vendor settlement (g) | - | (5,522) |
| Adjusted EBITDA | $40,560 | $34,324 |

(a) Represents LIFO adjustment, non-cash pension expense (income) and foreign exchange hedging.

(b) Represents non-cash stock options, restricted stock, incentives expense and Solace PRSUs.

(c) Represents the fees incurred for transaction expenses.

(d) Represents product launch costs for our new product lines.

(e) Represents costs associated with corporate and vapor restructuring including severance and inventory reserves.

(f) Represents costs associated with applications related to FDA PMTA.

(g) Represents costs associated with settlement of a vendor contract.

### Liquidity and Capital Reserves

Our principal uses for cash are working capital, debt service, and capital expenditures. We believe our cash flows from operations and borrowing availability under our 2018 Revolving Credit Facility are adequate to satisfy our operating cash requirements for the foreseeable future. We have $46.4 million of availability under the 2018 Revolving Credit Facility at June 30, 2020.

Our working capital, which we define as current assets less current liabilities, decreased $23.8 million to $109.6 million at June 30, 2020, compared with $133.4 million at December 31, 2019. The decrease is mainly related to the decrease in cash as a result of the June 2020 Durfort acquisition.

*(in thousands)*

|  | As of June 30, 2020 | December 31, 2019 |
| --- | ---: | ---: |
| Current assets | $161,561 | $189,250 |
| Current liabilities | 51,954 | 55,886 |
| Working capital | $109,607 | $133,364 |

42

#### Cash Flows from Operating Activities

For the six months ended June 30, 2020, net cash provided by operating activities was $17.5 million compared to net cash provided by operating activities of $21.7 million for the six months ended June 30, 2019, a decrease of $4.2 million, primarily due to lower net income due to the PMTA expenses in the current year, offset by increased amortization of debt discount and deferred financing costs.

#### Cash Flows from Investing Activities

For the six months ended June 30, 2020, net cash used in investing activities was $39.7 million compared to net cash used in investing activities of $0.3 million for the six months ended June 30, 2019, a decrease of $39.4 million, primarily due to the acquisition of certain assets from Durfort.

#### Cash Flows from Financing Activities

For the six months ended June 30, 2020, net cash used in financing activities was $8.9 million compared to net cash used in financing activities of $20.9 million for the six months ended June 30, 2019, an increase in cash flow of $12.0 million, primarily due to the payment of the revolving credit facility and second lien term loan in 2019.

#### Dividends and Share Repurchase

The most recent dividend of $0.05 per common share was paid on July 10, 2020, to shareholders of record at the close of business on June 19, 2020.

On February 25, 2020, our Board of Directors approved a $50.0 million share repurchase authorization, which is intended for opportunistic execution based upon a variety of factors including market dynamics. The authorization is subject to the ongoing discretion of the Board. The total number of shares repurchased for the six months ended June 30, 2020, was 256,863 shares for a total cost of $5.3 million and an average price per share of $20.59.

### Long-Term Debt

As of June 30, 2020, we were in compliance with the financial and restrictive covenants of the 2018 Credit Facility. The following table provides outstanding balances of our debt instruments.

|  | June 30, 2020 | December 31, 2019 |
| --- | ---: | ---: |
| 2018 First Lien Term Loan | $141,000 | $146,000 |
| Convertible Senior Notes | 172,500 | 172,500 |
| Note payable - Promissory Note | 10,000 | - |
| Note payable - Unsecured Loan | 7,485 | - |
| Note payable - IVG | - | 4,240 |
| Gross notes payable and long-term debt | 330,985 | 322,740 |
| Less deferred finance charges | (5,778) | (6,466) |
| Less debt discount | (28,583) | (32,083) |
| Less current maturities | (12,000) | (15,240) |
| Notes payable and long-term debt | $284,624 | $268,951 |

43

#### 2018 Credit Facility

On March 7, 2018, we entered into a $250 million credit facility consisting of a $160 million 2018 First Lien Term Loan with Fifth Third Bank, as administrative agent, and other lenders, and a $50 million 2018 Revolving Credit Facility (collectively, the “2018 First Lien Credit Facility”) in addition to a $40 million 2018 Second Lien Term Loan ( the “2018 Second Lien Credit Facility,” and, together with the 2018 First Lien Credit Facility, the “2018 Credit Facility”) with Prospect Capital Corporation, as administrative agent, and other lenders. The 2018 Credit Facility retained the $40 million accordion feature of the 2017 Credit Facility.

The 2018 Credit Facility contains customary events of default including payment defaults, breaches of representations and warranties, covenant defaults, cross-defaults to certain other material indebtedness in excess of specified amounts, certain events of bankruptcy and insolvency, certain ERISA events, judgments in excess of specified amounts, and change in control defaults. The 2018 Credit Facility also contains certain negative covenants customary for facilities of these types including covenants that, subject to exceptions described in the 2018 Credit Facility, restrict our ability: (i) to pledge assets, (ii) to incur additional indebtedness, (iii) to pay dividends, (iv) to make distributions, (v) to sell assets, and (vi) to make investments. Refer to Note 19, “Dividends and Share Repurchases”, of Notes to Consolidated Financial Statements for further information regarding dividend restrictions.

**2018 First Lien Credit Facility:** The 2018 First Lien Term Loan and the 2018 Revolving Credit Facility bear interest at LIBOR plus a spread of 2.75% to 3.50% based on our senior leverage ratio. The 2018 First Lien Term Loan has quarterly required payments of $2.0 million beginning June 30, 2018, increasing to $3.0 million on June 30, 2020, and increasing to $4.0 million on June 30, 2022. The 2018 First Lien Credit Facility has a maturity date of March 7, 2023. The 2018 First Lien Term Loan is secured by a first priority lien on substantially all of the assets of the borrowers and the guarantors thereunder, including a pledge of our capital stock, other than certain excluded assets (the “Collateral”). In connection with the Senior Notes offering, we entered into a First Amendment (“the Amendment”) to the First Lien Credit Agreement, with Fifth Third Bank, as administrative agent, and other lenders and certain other lending other lending parties thereto. The Amendment was entered into primarily to permit us to issue up to $200 million of convertible senior notes, enter into certain capped call transactions in connection with the issuance of such notes and to use the proceeds from the issuance of the notes to repay amounts outstanding under our 2018 Second Lien Credit Facility and use the remaining proceeds for acquisitions and investments. In connection with the Amendment, fees of $0.7 million were incurred. The 2018 First Lien Credit Facility contains certain financial covenants, which were amended in connection with the Convertible Senior Notes offering in the third quarter 2019. The covenants include maximum senior leverage ratio of 3.00x with step-downs to 2.50x, a maximum total leverage ratio of 5.50x with step-downs to 5.00x, and a minimum fixed charge coverage ratio of 1.20x. In the first quarter of 2020, the financial covenants were amended to permit certain add-backs related to PMTA in the definition of Consolidated EBITDA for the period of October 1, 2019 until September 30, 2020. In connection with the amendment, fees of $0.2 million were incurred. Based on an excess cash covenant for the facility, a principal payment of $4.5 million was due in the second quarter 2019. All parties agreed to waive the payment, resulting in consent fees of $0.1 million. The weighted average interest rate of the 2018 First Lien Term Loan was 2.93% at June 30, 2020. At June 30, 2020, we had no borrowings outstanding under the 2018 Revolving Credit Facility. The $50.0 million unused portion of the 2018 Revolving Credit Facility is reduced by letters of credit from Fifth Third Bank totaling $3.6 million, resulting in $46.4 million of availability under the 2018 Revolving Credit Facility at June 30, 2020.

**2018 Second Lien Credit Facility:** The 2018 Second Lien Credit Facility bore interest at a rate of LIBOR plus 7.00% and had a maturity date of March 7, 2024. The 2018 Second Lien Term Loan was secured by a second priority interest in the Collateral and was guaranteed by the same entities as the 2018 First Lien Term Loan. Based on an excess cash covenant for the facility, a $4.5 million principal payment was made in the second quarter 2019, resulting in $0.2 million loss on extinguishment of debt. We used a portion of the proceeds from the issuance of the Convertible Senior Notes to prepay all outstanding amounts related to the 2018 Second Lien Credit Facility in the third quarter 2019. The principal paid in the third quarter 2019 amounted to $35.5 million, and the transaction resulted in a $1.2 million loss on extinguishment of debt.

#### Convertible Senior Notes

In July 2019 we closed an offering of $172.5 million in aggregate principal amount of our 2.50% Convertible Senior Notes due July 15, 2024 (the “Convertible Senior Notes”). The Convertible Senior Notes bear interest at a rate of 2.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The Convertible Senior Notes will mature on July 15, 2024, unless earlier repurchased, redeemed or converted. The Convertible Senior Notes are senior unsecured obligations.

The Convertible Senior Notes are convertible into approximately 3,202,808 shares of our voting common stock under certain circumstances prior to maturity at a conversion rate of 18.567 shares per $1,000 principal amount of the Convertible Senior Notes, which represents a conversion price of approximately $53.86 per share, subject to adjustment under certain conditions, but will not be adjusted for any accrued and unpaid interest. Upon conversion, we may pay cash, shares of our common stock or a combination of cash and stock, as determined by us at our discretion. The conditions required to allow the holders to convert their Convertible Senior Notes were not met as of June 30, 2020.

Under GAAP, certain convertible debt instruments that may be settled in cash on conversion are required to be separately accounted for as liability and equity components of the instrument in a manner that reflects the issuer’s non-convertible debt borrowing rate. Accordingly, in accounting for the issuance of the Convertible Senior Notes, we separated the Convertible Senior Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated conversion feature. The carrying amount of the equity component, which is recognized as a debt discount, represents the difference between the proceeds from the issuance of the Convertible Senior Notes and the fair value of the liability component of the Convertible Senior Notes. The excess of the principal amount of the liability component over its carrying amount (“debt discount”), $35.0 million, will be amortized to interest expense using an effective interest rate of 7.5% over the expected life of the Convertible Senior Notes. The equity component is not remeasured as long as it continues to meet the criteria for equity classification. Interest expense includes $1.8 million of amortization for the three months ended June 30, 2020.

In accounting for the debt issuance costs related to the issuance of the Convertible Senior Notes, we allocated the total amount incurred to the liability and equity components based on their relative values. Debt issuance costs attributable to the liability component are amortized to the interest expense using the effective interest method over the expected life of the Convertible Senior Notes, $4.7 million, and the debt issuance costs attributable to the equity component, $1.2 million, are netted with the equity component of stockholders’ equity (deficit).

In connection with the Convertible Senior Notes offering, we entered into privately negotiated capped call transactions with certain financial institutions. The capped call transactions have a strike price of $53.86 per and a cap price of $82.86 per, and are exercisable when, and if, the Convertible Senior Notes are converted. We paid $20.53 million for these capped calls and charged that amount to additional paid-in capital.

#### Promissory Note

On June 10, 2020, in connection with the acquisition of certain Durfort assets, we issued an unsecured subordinated promissory note (“Promissory Note”) in the principal amount of $10.0 million (the “Principal Amount”), with an annual interest rate of 7.5%, payable quarterly, with the first payment due September 10, 2020. The Principal Amount is payable in two $5.0 million installments, with the first installment due 18 months after the closing date of the acquisition (June 10, 2020), and the second installment due 36 months after the closing date of the acquisition. The second installment is subject to reduction for certain amounts payable by us as a holdback.

#### Unsecured Loan

On April 6, 2020, the 2018 First Lien Credit Facility was amended to allow for an unsecured loan under the Coronavirus Aid, Relief, and Economic Security Act of 2020 (“CARES”). On April 17, 2020, National Tobacco Company, L.P., a wholly-owned subsidiary of the Company, entered into a loan agreement with Regions Bank guaranteed by the Small Business Administration for a $7.5 million unsecured loan. The proceeds of the loan were received on April 27, 2020. The loan is scheduled to mature on April 17, 2022 and has a 1.00% interest rate.

#### Note Payable – IVG

In September 2018, we issued a note payable to IVG’s former shareholders (“IVG Note”). The IVG Note was $4.0 million principal with 6.0% interest compounding annually and matured on March 5, 2020. All principal and accrued and unpaid interest under the IVG Note were subject to indemnification obligations of the sellers pursuant to the International Vapor Group Stock Purchase Agreement dated as of September 5, 2018. The carrying amount of the IVG Note, $4.2 million, was deposited into an escrow account pending agreement with the sellers of any indemnification obligations.

### Off-balance Sheet Arrangements

During the three months and six months ended June 30, 2020 and the year ended December 31, 2019 we did not execute any forward contracts. At June 30, 2020, and December 31, 2019, we did not have any forward contracts. The Company had interest rate swap contracts for a notional amount of $70 million at June 30, 2020 and December 31, 2019. The fair values of the interest rate swap contracts are based upon quoted market prices and resulted in a liability of $4.7 million and $2.5 million, respectively, as of June 30, 2020 and December 31, 2019, included in other long-term liabilities.

### Inflation

We believe that any effect of inflation at current levels will be minimal. Historically, we have been able to increase prices at a rate equal to or greater than that of inflation and believe that we will continue to be able to do so for the foreseeable future. In addition, we have been able to maintain a relatively stable variable cost structure for our products due, in part, to our successful procurement with regard to our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.

## Market risk

As filed, 2,196 characters.

### Foreign Currency Sensitivity

There have been no material changes in our exposure to exchange rate fluctuation risk, as reported within our 2019 Annual Report on Form 10-K, during the period. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2019 Annual Report on Form 10-K filed with the SEC.

### Credit Risk

There have been no material changes in our exposure to credit risk, as reported within our 2019 Annual Report on Form 10-K, during the three months ended June 30, 2020. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2019 Annual Report on Form 10-K filed with the SEC.

### Interest Rate Sensitivity

We have exposure to interest rate volatility principally related to interest rate changes applicable to loans under our 2018 Credit Facility. As of June 30, 2020, our 2018 Credit Facility bears interest at variable rates. However, we had swap contracts for a total notional amount of $70 million at June 30, 2020. The fair values of the swap contracts are based upon quoted market prices and resulted in a liability of $4.7 million as of June 30, 2020. We believe the effect, if any, of reasonably possible near-term changes in interest rates on our consolidated financial position, results of operations, or cash flows would not be significant. A 1% increase in interest rates would change pre-tax income by approximately $0.7 million per year. Refer to Note 4, “Derivative Instruments”, of Notes to Consolidated Financial Statements for additional information regarding the interest rate swaps.

In July 2019, we issued Convertible Senior Notes with an aggregate principal amount of $172.5 million. We carry the Convertible Senior Notes at face value less amortized discount on the balance sheet. Since the Convertible Senior Notes bear interest at a fixed rate, we have no financial statement risk associated with changes in interest rates. However, the fair value of the Convertible Senior Notes changes when the market price of our stock fluctuates, or interest rates change. Our remaining debt instruments bear interest at fixed rates and are not subject to interest rate volatility.

## Controls and procedures

As filed, 1,328 characters.

We have carried out an evaluation under the supervision, and with the participation of, our management including our Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), and Chief Accounting Officer (“CAO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended (the “Act”)) as of June 30, 2020. Based upon the evaluation, our CEO, CFO, and CAO concluded our disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by us in the reports we file or submit under the Act is: (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosures.

There have been no changes in the Company’s internal control over financial reporting during the fiscal quarter ended June 30, 2020 which have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 289 characters.

In addition to the other information set forth in this report, carefully consider the factors discussed in the ‘Risk Factors’ section contained in our 2019 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the 2019 Annual Report on Form 10-K.

Filed Jul 28, 2020.
Source: SEC EDGAR, the filing index for accession 0001140361-20-016862. Last ingested by Listed: Nov 10, 2026, 02:39 ET. No prices; not investment advice.
